A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer

作者: K Caca , N Prasnikar , F Kullmann , H Günther Derigs , M Koenigsmann

DOI: 10.1038/BJC.2012.555

关键词:

摘要: A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients advanced or metastatic non-small cell lung cancer

参考文章(26)
S. Al-Batran, R. Hofheinz, N. Homann, G. Illerhaus, U. M. Martens, J. Stoehlmacher-Williams, H. Schmalenberg, K. B. Luley, N. Prasnikar, M. Egger, S. Probst, J. T. Hartmann, M. H. Moehler, D. Arnold, W. Fischbach, C. Pauligk, S. P. Moenig, P. Piso, E. Jaeger, Defining two prognostic groups of metastatic gastric cancer: FLOT3 trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Journal of Clinical Oncology. ,vol. 29, pp. 4070- 4070 ,(2011) , 10.1200/JCO.2011.29.15_SUPPL.4070
Charles H. Weissman, Craig H. Reynolds, Marcus A. Neubauer, Sharon Pritchard, Svetlana Kobina, Lina Asmar, A Phase III Randomized Trial of Gemcitabine–Oxaliplatin versus Carboplatin–Paclitaxel as First-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer Journal of Thoracic Oncology. ,vol. 6, pp. 358- 364 ,(2011) , 10.1097/JTO.0B013E3181FFE8EF
A. Radhakrishnan, J.D. Bitran, D.T. Milton, K. Tolzien, S. Hallmeyer, C. Nabhan, Docetaxel and oxaliplatin as first-line therapy for advanced non-small cell lung cancer: a phase II trial. Journal of Chemotherapy. ,vol. 21, pp. 439- 444 ,(2009) , 10.1179/JOC.2009.21.4.439
Olivier Mir, Jérôme Alexandre, Stanislas Ropert, Vincent Montheil, Idalie Martin, Jean-Philippe Durand, François Goldwasser, Vinorelbine and oxaliplatin in stage IV nonsmall cell lung cancer patients unfit for cisplatin: a single-center experience. Anti-Cancer Drugs. ,vol. 20, pp. 105- 108 ,(2009) , 10.1097/CAD.0B013E32831CDB51
Jean-Pierre Caussanel, Francis Lévi, Silvano Brienza, Jean-Louis Misset, Moshe Itzhaki, René Adam, Gérard Milano, Bernard Hecquet, Georges Mathé, Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate. Journal of the National Cancer Institute. ,vol. 82, pp. 1046- 1050 ,(1990) , 10.1093/JNCI/82.12.1046
Salah-Eddin Al-Batran, Claudia Pauligk, Nils Homann, Jörg T. Hartmann, Markus Moehler, Stephan Probst, Volker Rethwisch, Jan Stoehlmacher-Williams, Nicole Prasnikar, Stephan Hollerbach, Carsten Bokemeyer, Rolf Mahlberg, Ralf D. Hofheinz, Kim Luley, Frank Kullmann, Elke Jäger, The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: A randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+) European Journal of Cancer. ,vol. 49, pp. 835- 842 ,(2013) , 10.1016/J.EJCA.2012.09.025
F Cappuzzo, S Novello, F De Marinis, V Franciosi, M Maur, A Ceribelli, V Lorusso, F Barbieri, L Castaldini, E Crucitta, L Marini, S Bartolini, G V Scagliotti, L Crinò, Phase II study of gemcitabine plus oxaliplatin as first-line chemotherapy for advanced non-small-cell lung cancer British Journal of Cancer. ,vol. 93, pp. 29- 34 ,(2005) , 10.1038/SJ.BJC.6602667
M. Früh, S. Gillessen, T. Cerny, R. Demmer, G. D’Addario, Two-weekly gemcitabine fixed dose rate and oxaliplatin combination chemotherapy for advanced non-small-cell lung cancer Lung Cancer. ,vol. 62, pp. 344- 350 ,(2008) , 10.1016/J.LUNGCAN.2008.03.028
Salah-Eddin Al-Batran, Joerg Thomas Hartmann, Stephan Probst, Harald Schmalenberg, Stephan Hollerbach, Ralf Hofheinz, Volker Rethwisch, Gernot Seipelt, Nils Homann, Gerhard Wilhelm, Gunter Schuch, Jan Stoehlmacher, Hans Günter Derigs, Susanna Hegewisch-Becker, Johannes Grossmann, Claudia Pauligk, Akin Atmaca, Carsten Bokemeyer, Alexander Knuth, Elke Jäger, Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. Journal of Clinical Oncology. ,vol. 26, pp. 1435- 1442 ,(2008) , 10.1200/JCO.2007.13.9378